CLINICAL_TRIALS
trial_result
· 2024-05-29
Clinical Trial Update: Safety and Immunogenicity of Purified Verocell Rabies Vaccine PVRV Administered Intramuscularly and Intradermally [Phase 4]
Summary
Phase 4 clinical trial update assessing the safety and immunogenicity of Purified Verocell Rabies Vaccine (PVRV) administered intramuscularly and intradermally.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of Peshawar | Conditions: Rabies | Phase 4 | Status: COMPLETED